Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984;26(2):197-207.
doi: 10.1007/BF00630286.

Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis

Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis

M M Hammarlund et al. Eur J Clin Pharmacol. 1984.

Abstract

Furosemide 40 mg was administered to 8 healthy subjects as an i.v. bolus dose, as 1 tablet in the fasting state, and as 1 tablet and a solution after food intake. The i.v. data gave a total body clearance of 162 +/- 10.8 ml/min and a renal clearance of 117 +/- 11.3 ml/min; the volume of distribution at steady state was 8.3 +/- 0.61. Oral administration gave a bio-availability of the tablet (fasting) of 51%. Food intake slightly reduced the bioavailability, but not to a significant extent. There was no significant difference in availability between the tablet and the solution. Moment analysis gave a mean residence time after the i.v. dose, MRTi .v., of 51 +/- 1.5 min. The mean absorption times (MAT) for all oral doses were significantly longer than the MRTi .v., indicating absorption rate-limited kinetics of furosemide. On average, food delayed the absorption by 60 min. The MAT for the tablet in the postprandial state was significantly longer than for the solution, indicating dissolution rate-limited absorption of the tablet.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 1974 Feb;15(2):178-86 - PubMed
    1. J Pharm Sci. 1982 Oct;71(10):1105-8 - PubMed
    1. Clin Pharmacol Ther. 1978 Oct;24(4):420-31 - PubMed
    1. J Pharmacokinet Biopharm. 1979 Feb;7(1):1-27 - PubMed
    1. Eur J Clin Invest. 1982 Jun;12(3):247-55 - PubMed

LinkOut - more resources